QuadraSphere Microspheres
Device, Vascular, For Promoting Embolization. 510(k) K153102, from Biosphere Medical, S.A. (Roissy-En-France, FR). Product code KRD, class 2.
As of Nov 17, 2026, K153102 is an FDA 510(k) held by Biosphere Medical, S.A., substantially equivalent on Nov 23, 2015 after 28 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Nov 23, 2015
- Review time: 28 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFQuadraSphere Microspheres are indicated for embolization of hypervascularized tumors including hepatoma, and peripheral arteriovenous malformations.
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- QuadraSphere MicrospheresK172372 · Biosphere Medical, S.A. · Sep 6, 2017
Other KRD Clearances
The newest 510(k)s for the same product code; their median review was 70 days; see every KRD device- LOBO Vascular Occlusion SystemK262798 · Okami Medical, Inc. · Oct 6, 2026
- UniPearls® Embolic MicrospheresK252812 · Suzhou Haowei Medical Technology Co., Ltd. · Jul 31, 2026
- OBSIDIO Conformable EmbolicK261488 · Boston Scientific Corporation · Jul 24, 2026
- Concerto Versa Detachable CoilK261866 · Medtronic, Inc. · Jun 24, 2026
- HARBOR Occlusion DeviceK260635 · Nuvascular, Inc. · Jun 12, 2026
- LOBO Vascular Occlusion SystemK260508 · Okami Medical, Inc. · Apr 10, 2026
- Concerto Versa Detachable CoilK253511 · Medtronic, Inc. · Jan 14, 2026
- Tembo Embolic SystemK253677 · Instylla, Inc. · Dec 15, 2025
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Oct 26, 2015
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.3300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files